💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Biogen Inc. (BIIB)
« Back to company indexBIIB Chatter Timeline
Stock Ticker for BIIB
Most Active Tweeters for BIIB
| User | Tweets |
|---|---|
| @slay_ad | 53 |
| @SweepCastApp | 13 |
| @planert41 | 9 |
| @drysvictim | 9 |
| @bs_marker | 9 |
Recent Tweets for BIIB
 |
@julia_aptx4869 RT @bradloncar: The gov't filmed the negotiation with $BIIB for Spinraza (to make an example of of them, I guess). It's all over social med… 4:12am |
 |
@newsfilterio $22,167.34 of shares sold by Biogen Inc. (10% Owner), reported in a new form 4 filed with the SEC $BIIB https://t.co/hQIg7u3wXv 4:12am |
 |
@bradloncar The gov't filmed the negotiation with $BIIB for Spinraza (to make an example of of them, I guess). It's all over so… https://t.co/2PeGzPKhAE December 3rd 2021, 10:12pm |
 |
@TradeWithAlerts A nice print for $BIIB at 5:31pm -- SIDE: Between Click https://t.co/FermWOFDda for more. Runners ?:… https://t.co/sVDCD9iDX0 December 3rd 2021, 10:12pm |
 |
@otcdynamics $BIIB Biogen Leads From the Top With Disability Inclusion https://t.co/eyirraoxcV December 3rd 2021, 10:12pm |
 |
@slay_ad "...we cannot let that happen..." $BIIB https://t.co/MHCjDsUjyN December 3rd 2021, 10:12pm |
|
@slay_ad $BIIB just can't catch a breath! https://t.co/xCTMVIqbEu December 3rd 2021, 10:12pm |
 |
@AAMortazavi Is it my imagination or are $BIIB selling scraps of their stake in $SGMO? Below where they bought them less than 2 years ago. December 3rd 2021, 9:12pm |
 |
@FlashAlert_me $BIIB [15s. delayed] filed SEC form 4: 10% Owner BIOGEN INC.: Disposed 2,604 of Common Stock at average price $8.5… https://t.co/RzH7PSPDsQ December 3rd 2021, 9:12pm |
 |
@dailycandlestix $BIIB Major Breakdown Daily appearances since 2010: 75 Close 5 days later ±: Avg: 5.27 SD: 19.00 Worst: -22.92 Best… https://t.co/ykaAqmIvgy December 3rd 2021, 9:12pm |
|
@slay_ad $BIIB went all the way to 221.75 today!?? December 3rd 2021, 8:12pm |
 |
@bs_marker Stock: $BIIB - Biogen *** NEWS *** Q4 2022 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Reduced by William Blair - M… https://t.co/ZvJNifSf5S December 3rd 2021, 8:12pm |
 |
@drysvictim i still remember third of december $BIIB was trading better than it is now-- one year later why are there so many… https://t.co/FXxhrZhdut December 3rd 2021, 8:12pm |
 |
@Mike_Taylor1972 @BiotechObserver $BIIB very hard to be an activist on a dumpsterfire. https://t.co/N0z4nXhPve December 3rd 2021, 8:12pm |
 |
@happyycamperr wow...I didnt think $BIIB would take out it reaction lows of 225! But it did-at least revisit....maybe time to look again? December 3rd 2021, 7:12pm |
 |
@Tickeron $BIIB's Aroon indicator drops into Downtrend on November 19, 2021. View odds for this and other indicators:… https://t.co/mi36X1g2FF December 3rd 2021, 6:12pm |
 |
@tonythearena When was the last time $biib closed up? December 3rd 2021, 6:12pm |
|
@slay_ad so flawlessly in the middle of a pandemic - not to be dissing on $BIIB, but look at the chaos and fiasco they have… https://t.co/Jiu1C73We4 December 3rd 2021, 6:12pm |
 |
@mattj_d @ripster47 Thanks so much! $BIIB puts!! paying again! https://t.co/u1cUrRTIq8 December 3rd 2021, 5:12pm |
 |
@BiotechObserver $NVAX Fire Stan $BIIB Fire whoever the fuck Where are the activist investors man lol December 3rd 2021, 5:12pm |
|
@mattj_d @ripster47 Dont forget $BIIB doing the same! Thank you! December 3rd 2021, 2:12pm |
 |
@ResearchPool $BIIB #Biogen ... Weekly Neurology Prescription Sales Tracker -- Week Ending 11/26/21: [...]… https://t.co/VejAtr2Hty December 3rd 2021, 1:12pm |
|
@bs_marker Stock: $BIIB - Biogen *** NEWS *** Q4 2022 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Reduced by William Blair - M… https://t.co/0Njl4WEkPd December 3rd 2021, 12:12pm |
 |
@StckPro $BIIB NEW ARTICLE : Should You Blame Biogen for Medicare Part B Premium Hikes? https://t.co/l1nvlNO8Ep Get all the… https://t.co/38OBUycqvE December 3rd 2021, 11:12am |
 |
@R5ive8 $BIIB almost close to 5 year low December 3rd 2021, 3:12am |
 |
@MarcJacksonLA $SAGE $BIIB Sage Therapeutics, Biogen highlight data showing zuranolone well-tolerated in MDD https://t.co/n8a4ZITgFg December 3rd 2021, 1:12am |
 |
@SweepCastApp SweepCast alerted: $BIIB with Unusual Options Activity Alerted on $265 CALL Expiring: 01-21-2022 worth 30K? |? Chec… https://t.co/HUEzz8MCvf December 3rd 2021, 1:12am |
 |
@CapitalBleed RT @CapitalBleed: Crime--in this case, attempted robbery of U.S. taxpayers of hundreds of billions of dollars--doesn't pay, $BIIB December 3rd 2021, 1:12am |
 |
@lipa0902 @gcbioinv @Sanctuary_Bio I think amyloid theory is not dead. Both $BIIB and $LLY have seen some tantalizing hint of… https://t.co/LHhvelIZ4W December 3rd 2021, 12:12am |
|
@slay_ad Aduhelm's time is nearing I think the stars have turned against $BIIB look at that stock since approval - in the… https://t.co/BOh4r1t4m3 December 2nd 2021, 11:12pm |
|
@slay_ad I wouldn't touch $BIIB with...anything, forget 10 ft pole woes aren't over stars have turned https://t.co/CsjrnKZeIJ December 2nd 2021, 11:12pm |
 |
@auditor112017 @ByMadeleineA $biib $ions We should see some data next year on phase 1 MSA (7/13/22). https://t.co/BVDP57xv80 December 2nd 2021, 11:12pm |
|
@auditor112017 @ByMadeleineA $biib has an ASO that goes after this target! ION464/BIIB101. ION464 is designed to prevent the produ… https://t.co/Rce6Wnq375 December 2nd 2021, 11:12pm |
|
@dailycandlestix $BIIB Major Breakdown Daily appearances since 2010: 74 Close 5 days later ±: Avg: 5.59 SD: 18.92 Worst: -22.92 Best… https://t.co/gRqKp3nUz5 December 2nd 2021, 9:12pm |
 |
@Sanctuary_Bio I feel gross just saying this, but it's hard to imagine things at $BIIB can get much worse. Aduhelm launch, clinica… https://t.co/r2Bq4VL2gw December 2nd 2021, 8:12pm |
 |
@chiragontwtr Reminds me of $FWP 's win against $BIIB. https://t.co/dppcvHJRIE https://t.co/dxDZjyVoks December 2nd 2021, 6:12pm |
 |
@sentivcapital Interesting side-note: $BIIB (long) vs $VTRS Tecfidera has a decent chance of going to En Banc trial. Ruling was a… https://t.co/h7itSzO8aw December 2nd 2021, 5:12pm |
|
@mattj_d @ripster47 $BIIB thanks so much for the early put idea! ??? following the trend! December 2nd 2021, 3:12pm |
 |
@BioWino $biib 18 rsi.. that's pretty low for a big cap. r/r December 2nd 2021, 3:12pm |
 |
@Buy100ozSilver What's the issue with companies like Biogen $BIIB /Amgen $AMGN etc... pipeline issues? Priced like it..... December 2nd 2021, 3:12pm |
|
@mattj_d @ripster47 $BIIB puts! Thanks Rip! Let’s go!! Steady paying! December 2nd 2021, 2:12pm |
|
@drysvictim i admit that i am horny for the ballsy investors who shorted $BIIB after aduhelm approval https://t.co/hFI6ozZZQ6 December 2nd 2021, 5:12am |
 |
@optioncharts $BIIB Implied Volatility expiration 12/03/2021 #maxpain #options https://t.co/dMCcEFOVlk https://t.co/Fuc56vbVSr December 1st 2021, 10:12pm |
|
@TradeWithAlerts A nice print for $BIIB at 5:36pm -- SIDE: Between Click https://t.co/FermWOFDda for more. Runners ?:… https://t.co/2TpwkH2Xb6 December 1st 2021, 10:12pm |
|
@BioWino @Sanctuary_Bio well.. they did just win a patent trial against the hottest name on the market. $biib should buy them just for the lawyers. December 1st 2021, 8:12pm |
|
@SweepCastApp SweepCast alerted: $BIIB with Unusual Options Activity Alerted on $245 CALL Expiring: 12-03-2021 worth 49K? |? Chec… https://t.co/KcmepodeDq December 1st 2021, 6:12pm |
 |
@MarketCharts $BIIB has been declining for 5 days in a row. Chart: https://t.co/iaLh4IM2Wr December 1st 2021, 6:12pm |
|
@slay_ad RT @slay_ad: $BIIB History will tell that FDA approving Aduhelm was the final nail in the amyloid-beta coffin! December 1st 2021, 6:12pm |
|
@slay_ad RT @slay_ad: $BIIB Oh, and speaking of safety, Aria/brain swelling killed one of the few people who took the drug. If I’m a Alzheimer’s p… December 1st 2021, 6:12pm |
|
@slay_ad RT @slay_ad: $BIIB Why was Aduhelm approved? Because it reduced amyloid plaque? But no real cognitive affect? Isn’t Alzheimer’s a dis… December 1st 2021, 6:12pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?